Serum estradiol should be monitored not only during the peri-menopausal period but also the post-menopausal period at the time of aromatase inhibitor administration

BACKGROUND: Aromatase inhibitor (AI) therapy is being extensively used as postoperative adjuvant therapy in patients with hormone receptor-positive postmenopausal breast cancer. On the other hand, it has been reported that ovarian function was restored when AI was administered to patients who had un...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagao, Taeko, Kira, Misako, Takahashi, Masako, Honda, Junko, Hirose, Toshiyuki, Tangoku, Akira, Zembutsu, Hitoshi, Nakamura, Yusuke, Sasa, Mitsunori
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779795/
https://www.ncbi.nlm.nih.gov/pubmed/19909552
http://dx.doi.org/10.1186/1477-7819-7-88

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779795/
https://www.ncbi.nlm.nih.gov/pubmed/19909552
http://dx.doi.org/10.1186/1477-7819-7-88

Ejemplares similares